CBSA June Focus Newsletter Spotlights AlloSource, the largest provider of living stem cell transplants in the world

The Colorado Bioscience Association spotlights AlloSource in its June Focus Newsletter.

"AlloSource, a CBSA member since 2002 that is headquartered in Centennial, is renowned for its unwavering focus on its mission of maximizing the gift of human tissue donation by creating innovative life enhancing and saving tissue products from even the most novel processes."

Other articles include:

From the President...Holli Riebel (formerly Baumunk) - Page 1

BioBogey Golf Tournament Thank You - Page 3

Upcoming CBSA Events - Page 4

Link to the June Focus Newsletter pdf

Link to the AlloSource website

CID4 Portfolio: 'VetDC hopes money will lead to canine cancer drug on market'

Quoting from the Coloradoan article by Business Editor Pat Ferrier:

"A small CSU biotech spinoff developing a cancer drug for dogs has become the third company to partner with Colorado Institute for Drug, Device and Diagnostic Development, CID4, since the statewide institute was formed in 2009...

Veterinary Emerging Technologies Development Corporation, or VetDC, will get $200,000 in bridge financing, management support and key introductions to potential venture capitalists from CID4, a 2-year-old nonprofit designed to grow the state's biosciences...

VetDC hopes to leverage the $200,000 convertible notes from CID4 into $7 million to $8 million in venture or angel capital to develop and bring a new canine cancer drug to market...

VetDC acquired the North American rights to the chemotherapy drug, VDC-1101, earlier this year from Gilead Sciences."

Link to full article at coloradoan.com

2011 Bioscience Colorado Magazine Debuts at BIO International Conference in Washington D.C. This Week

This year's issue, Bridging the Gap from Discovery to Commercialization, takes a closer look at the process from discovery to commercialization with the following feature articles:

Discovery to Development: The Story of Technology Transfer
When the Going Gets Tough, the Tough Get Creative Financing
Colorado's Clinical Trial Landscape
Mile High Manufacturing
Changing the Lives of Patients for the Better

The edition also includes critical updates of the resources, statistics and information you depend on from this publication.

Colorado by the Numbers: 2011 update
Bioscience Discovery Evaluation Grant Program Awardees
Directory of Bioscience Companies and Resources

Member copies will be mailed this week- additional copies will be available at upcoming CBSA events.

Link to the pdf version

Link to the flipbook version

'Colorado companies head to Washington to promote state'

Quoting from the Denver Post article by Howard Pankratz:

"The Colorado BioScience Association will head the Colorado Pavilion at the Biotechnology Organization's international convention which starts today in Washington.

The CBSA is a not-for-profit organization which provides service and support for Colorado's biosciences industry. The CBSA has more than 350 members."

Link to denverpost.com

Colorado Showcases Its Bioscience Industry at BIO 2011 Conference In Washington DC This Week

Colorado BioScience Association (CBSA) will head the Colorado Pavilion at the Biotechnology Industry Organization’s (BIO) International Convention in Washington DC, June 27-30. CBSA President and CEO, Holli Riebel (formerly Baumunk) recently stated, “Colorado is the next frontier in life sciences. Everyday, over 600 Colorado bioscience companies help improve lives locally and around the world. The BIO Conference is a fantastic opportunity so showcase the talent and resources in Colorado to the rest of the country.”

Colorado Pavilion Partners– Exhibit Hall Booth #2107
- Bridging Health Matters
- Broomfield Economic Development Corporation
- Colorado BioScience Association
- Colorado Institute for Drug, Device and Diagnostic Development (CID4)
- Colorado Office of Economic Development and International Trade
- Colorado Science + Technology Park at Fitzsimons
- Colorado State University Technology Transfer Office
- Fitzsimons Redevelopment Authority
- LABS Inc.
- LCC Consulting, LLC
- Metro Denver Economic Development Corporation
- Southeast Business Partnership
- University of Colorado Technology Transfer Office

Colorado companies at the 2011 Convention:
- Amgen • Booth #1851
- Barofold, Inc • Booth #4323
- CBL Biopharma • Presenting
- GlobeImmune, Inc. • Presenting
- Inviragen • Booth #4613
- MenoGenix • Partnering
- Roche Colorado • 2750

Link to the Business Wire release

From June 18: 'Organic Gardening with Fish Rich Fertilizer'

Quoting from The Suburban Jungle:

"My parents were organic gardeners by default - it was just how they were raised. Years later, I became an organic gardener - first out of laziness (who wants to figure out all the fertilizer/pesticide rules) and then out of concern for what is going into our bodies and our world.

So over my many years, I've come to know a thing or two about organic gardening. I've learned that by NOT fertilizing your plants, you end up with a much smaller harvest. I've learned that beyond the chemical impact, organic fertilizers provide a more complete nutrient profile - micronutrients, enzymes, trace minerals, etc. I've also learned that not all organic fertilizers are created equal."

Link to The Suburban Jungle

June 24 - Coloradoans for an Innovation Economy: Action Plan Rollout for Senators Bennet, Udall and Governor Hickenlooper

Coloradoans for an Innovation Economy present their action plan to Colorado's Senators Bennet and Udall and Governor Hickenlooper at Sierra Nevada Corp. Space Systems Group's offices in Louisville, CO. CBSA Pres/CEO Holli Riebel; Sierra Nevada Corp Vice President Mark Sirangelo; and Ron Sega, Vice President and Enterprise Executive for Energy and the Environment at Colorado State University; together co-chaired the panel. The group, organized at the suggestion of Senator Bennet, included representatives from the state's bioscience, aerospace and cleantech industries. In addition to Riebel, bioscience participants on the Coloradoans for and Innovation Economy include Steve Orndorf, CEO of Ariel Pharmaceuticals and Board Chair of the Colorado BioScience Association; Timothy C. Rodell, M.D., GlobeImmune CEO; Dr. Dan Stinchcomb, Co-founder and CEO of Inviragen; and David Allen, Associate Vice President for Technology Transfer University of Colorado and Board Member of the CBSA.

Link to the action plan report: http://tinyurl.com/ColoradoCompetesReport

Link to the Facebook photo gallery of the event: http://tinyurl.com/ColoradoCompetesPhotoGallery

Video clips from the presentation - Holli Riebel - Attracting Capital to Colorado:


http://youtu.be/2c6IHAylJPg

Holli Riebel - Partnerships are Key to Financing Innovation:
http://youtu.be/hDCh5FLEO1A

Timothy C. Rodell, M.D - BIO Committee Recommendation to FDA: http://youtu.be/XXliantUqR0